Cytosorbents (CTSO) 2025 Earnings Outlook for Investors
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Discover what are the best high return investments available today. Equip yourself with knowledge to enhance your investment strategy.
25,106 articlesInvestors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
The head of OURA says the CEO role is far tougher than imagined, revealing the psychological weight, team dynamics, a...
Two Wall Street giants raised price targets on Super Micro Computer after a solid Q3 2026 performance, but neither mo...
Diet discipline isn’t just about food. It affects your wallet, health, and goals. This guide explains the moments whe...
Joby Aviation reports modest quarterly revenue gains and robust cash reserves while advancing certification and inter...
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
April’s jobs report beat expectations with a surprising payroll gain, yet revisions and sector gaps create a murkier ...
Mah Sing shifts toward premium Kuala Lumpur residences and data-center land, citing Malaysia's strong growth as the d...
U.S. stocks push higher into May on AI-driven demand and resilient earnings, with analysts debating whether trump’s b...
Citi boosts its Broadcom price target to $500 on expectations of solid AI-driven revenue in the upcoming April quarte...
OpenAI CEO Sam Altman faces cross-examination in a federal court case brought by Elon Musk, defending his leadership ...
A small-cap AI marketing platform is selling at $0.91 per share in a Reg A+ offering, aiming to replicate early tech ...